ISMPP Highlights
2021 Member Research, FDA Action for Failure to Submit Clinical Trial Results for Posting, Guideline Updates
Learn from the scientific posters presented at the 2021 European Meeting of ISMPP in January and the 17th Annual Meeting of ISMPP in April. Find out about the first US FDA Notice of Noncompliance for failure to post clinical trial results on ClinicalTrials.gov, as well as an updated PRISMA Statement and a new CONSORT Extension…
An Exceptional 17th Annual Meeting Sets Attendance Record!
In what has been a unique year with facing the COVID-19 pandemic, changing practices for medical publications and communications, and adjusting to work from home and virtual congresses, ISMPP was especially thrilled to have over 650 attendees participate in our virtual 17th Annual Meeting, setting a NEW ATTENDANCE RECORD!…
Advocating for Pre-Publication Review – AMWA, EMWA, ISMPP Release Joint Position Statement
The public could lose trust in science if scientific and medical researchers choose to bypass the traditional high standards of peer-reviewed medical journals in the rush to get research data released, particularly during crises such as the COVID-19 pandemic. That’s the warning from three leading medical communications organizations that have published a Joint Statement…
Message from Our Leadership
Robert J. Matheis
ISMPP President and CEO
News and Trends
The Year in Review / The Year Ahead
“The Year in Review / The Year Ahead” highlights significant topics in the year 2020 that were selected by The MAP Working Group. Watch three members of The MAP Working Group introduce each topic in videos. Information is also provided about ISMPP resources covering the individual topics…
What I Would Like You to Know: A Medical Affairs Perspective
What are the key things you want your medical publication colleagues to know from your experience as a medical affairs professional? It is key to think strategically when working in the medical affairs profession. Developing a publication is not just creating a data dump from the clinical study report; it is telling a story out of that data…
Equity, Diversity, and Inclusion: Defining a Roadmap for Our Profession
A Call to Action to Medical Publication and Communication Professionals. With the weight of the COVID-19 pandemic upon us, the values of equity, diversity, and inclusion (EDI) have never been more visible nor played a more dynamic role in healthcare. As medical publication professionals, we have a crucial role in communicating scientific research accurately and truthfully…
What Would You Do?
In our role as medical publication professionals, we may occasionally encounter situations in which it is not obvious how to ensure good publication practice. Have you ever wished you could consult the ISMPP membership for guidance when these situations arise? Here’s your opportunity!
What Would You Do? is a section of The MAP that presents case scenarios as an educational tool for medical publication professionals. The section provides a case scenario to ponder, and readers are invited to participate in a poll by selecting one of the listed solutions. Readers can also submit their thoughts on the scenario anonymously. The poll results, plus educational insights, are posted in a later issue for readers to digest.
POLL RESULTS: Publication in a Predatory Journal
You are a medical publication professional and have been supporting a client with a secondary manuscript for a Phase 3 study. You recommended target journals and worked with the author team throughout the submission process. Following the publication, it becomes apparent that the manuscript was submitted to a predatory journal…
ISMPP (pronounced IzMap) is the only nonprofit organization founded by medical publication professionals for medical publication professionals